Mucosal type mast cells express complement receptor type 2 (CD21).
Fragments of complement component C3 generated upon activation of the cascade play an important role in the induction and regulation of immune responses. Receptors interacting with various fragments of this versatile complement protein are expressed on a wide variety of cell types, including lymphocytes, macrophages, dendritic cells, follicular dendritic cells, granulocytes, erythrocytes and consequently, C3-products may influence several biological functions at different sites of the body, where complement activation occurs. Regarding the expression of various C3-receptors on mast cells, mainly rodent serosal type mastocytes have been investigated so far. It has been known for a long time that C3a triggers the release of mediators of immediate type hypersensitivity via binding to serosal-type cells. Complement receptor type 1 (CR1/CD35) and type 2 (CR2/CD21) interacting with the larger activation products, such as C3b and C3d, have so far been shown on serosal type mast cells only. In this study, the expression of CR1/2 on mucosal type mast cells is demonstrated. Using mouse CR1/2 specific single chain antibodies and the natural ligand C3d in cytofluorimetric measurements, we show that the rat mucosal mast cell line RBL-2H3 and mouse bone marrow-derived mast cells (BMMC) express CD21. RT-PCR experiments carried out with mouse CR1 and CR2 specific primers show CD21, but not CD35 specific products in BMMC. It is also demonstrated that, in contrast to serosal type mast cells, mucosal mastocytes do not express CD19. In an attempt to reveal the possible function of CR2 on mucosal type mast cells, the effect of receptor-clustering was tested regarding degranulation, Ca-response and IL-6 production, but no CR2-mediated change was detected in any of these processes.
Andrásfalvy
Márton
M
Department of Immunology, Eötvös Loránd University, Budapest, Hungary.
Prechl
József
J
Hardy
Tímea
T
Erdei
Anna
A
Bajtay
Zsuzsa
Z
D000818:Animals; D018941:Antigens, CD19 / Q000032:analysis; D001854:Bone Marrow Cells / Q000276:immunology; D002118:Calcium / Q000378:metabolism; D015550:Cell Degranulation; D002454:Cell Differentiation; D002478:Cells, Cultured; D018928:Immunity, Mucosal; D015850:Interleukin-6 / Q000096:biosynthesis; D008407:Mast Cells / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D019009:Proto-Oncogene Proteins c-kit / Q000032:analysis; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011940:Receptor Aggregation; D011951:Receptors, Complement / Q000032:analysis; D017464:Receptors, Complement 3d / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured
D018941:Antigens, CD19; D015850:Interleukin-6; D012333:RNA, Messenger; D011951:Receptors, Complement; D017464:Receptors, Complement 3d; D019009:Proto-Oncogene Proteins c-kit; D002118:Calcium